The cost effectiveness of levalbuterol versus racemic albuterol

American Journal of Managed Care

Volumn 10, Issue SUPPL. 5, 2004, Pages

  Quinn, Campion ^a  

^a Campion Quinn and Associates LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; ISOPRENALINE; LEVALBUTEROL; SALBUTAMOL;

AGITATION; ASTHMA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; ECONOMIC ASPECT; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERTENSION; ISOMER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; COST-BENEFIT ANALYSIS; HUMANS; STEREOISOMERISM; UNITED STATES;

EID: 3242756616     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Asthma Prevalence, Health Care Use, and Mortality, 2000-2001. National Center for Health Statistics, Centers for Disease Control and Prevention.
2. Data Fact Sheet: Asthma Statistics. National Heart, Lung, and Blood Institute, National Institutes of Health; January 1999.
3. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999;104:957-963.
4. Morbidity & Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Heart, Lung, and Blood Institute, National Institutes of Health, May 2002.
5. Surveillance for Asthma - United States, 1980-1999. Morbidity and Mortality Weekly Report Surveillance Summaries, Centers for Disease Control and Prevention, March 29, 2002.
6. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
7. Hoffman BB. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001.
8. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared to racemic albuterol in patients with asthma. J Allergy Clin Immunol. 1998;102:943-952.
9. Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA, Levalbuterol Pediatric Study Group. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol. 2001;108: 938-945.
10. Nowak RM, Emerman CL, Schaefer K, DiSantostefano RL, Vaickus L, Roach JM. Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study. Am J Emerg Med. 2004;22:29-36.
11. Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol in the treatment of asthma in pediatric patients. J Allergy Clin Immunol. 1999;103:615-621.
12. Schreck D, Brotea C, Shah S. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma. Ann Emerg Med. 2001;38:S10. Abstract.
13. Carl JC, Myers TR, Kirshner HL, Kercsmar CM. Comparison of racemic albuterol and levalbuterol in treatment of acute asthma. J Peds. 2003;143:731-736.
14. Truitt T, Witko J, Halpern M. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma. Chest. 2003;123:128-135.
15. Hendeles L, Hartzema A. Levalbuterol is not more cost-effective than albuterol for COPD (letter). Chest. 2003;124:1176-1178.
16. Sculpher MJ, Price M. Measuring costs and consequences in economic evaluation in asthma. Resp Med. 2003;97:508-520.
17. Eisenberg JM, Schulman KA, Glick H, Koffer H. Pharmacoeconomics: economic evaluation of pharmaceuticals. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. New York, NY: Wiley; 1994.
18. Sullivan S, Elixhauser A, Buist AS, Luce BR, Fisenberg J, Weiss KB. National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care. Am J Respir Crit Care Med. 1996;154(3 pt 2):S84-S95.